Showing results (31-40 of 693) with videos related to
Sort By:
Pageof 70
Revue Medicale De Liege|March 24, 2015
[Canagliflozin (Invokana): kidney SGLT2 cotransporter inhibitor for treating type 2 diabetes]A J ScheenDiabetes & Metabolism|August 5, 2020
Metformin and COVID-19: From cellular mechanisms to reduced mortalityA J ScheenRevue Medicale De Liege|June 23, 2006
[How I explore...outcomes in clinical trials: comments about recent studies of cardiovascular prevention]A J ScheenRevue Medicale De Liege|December 31, 2008
[Drug selection guided by known and newly diagnosed comorbidities in a multi-risk patient]A J ScheenRevue Medicale De Liege|September 10, 2020
[Ertugliflozin alone and in fixed-dose combinations : «pass of three»]A J ScheenRevue Medicale De Liege|June 22, 2018
[From atherosclerosis to atherothrombosis : from a silent chronic pathology to an acute critical event]A J ScheenRevue Medicale De Liege|June 26, 1998
[Drug clinics. The drug of the month. Alendronate (Fosamax)]A J ScheenExpert Review of Clinical Pharmacology|June 30, 2025
Progress towards a personalized management of antidiabetic medications in the elderly with type 2 diabetesA J ScheenAnnales D'Endocrinologie|January 5, 2000
[Benefits and limitations of protein diets in obese patients with type 2 diabetes]A J ScheenPageof 70